相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Jerold Chun et al.
CLINICAL NEUROPHARMACOLOGY (2010)
MULTIPLE SCLEROSIS Closing in on an oral treatment
Roland Martin
NATURE (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
Masaru Ishii et al.
NATURE (2009)
Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
Florian Mullershausen et al.
NATURE CHEMICAL BIOLOGY (2009)
Primary-progressive multiple sclerosis (vol 6, pg 903, 2007)
D. Miller et al.
LANCET NEUROLOGY (2009)
A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis
David Wheeler et al.
BRAIN (2008)
Astrocytes in multiple sclerosis: A product of their environment
A. Nair et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease
Yun-Ping Wu et al.
HUMAN MOLECULAR GENETICS (2008)
Central nervous system-directed effects of FTY720 (fingolimod)
Veronique E. Miron et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
May H. Han et al.
NATURE (2008)
Finding a way out: lymphocyte egress from lymphoid organs
Susan R. Schwab et al.
NATURE IMMUNOLOGY (2007)
Glia-dependent TGF-β signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis
Jian Luo et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis
Carolyn A. Foster et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Primary-progressive multiple sclerosis
David H. Miller et al.
LANCET NEUROLOGY (2007)
A crucial role for Olig2 in white matter astrocyte development
Jeff Cai et al.
DEVELOPMENT (2007)
Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate
Rajita Pappu et al.
SCIENCE (2007)
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubipuitinylation and proteasomal degradation of the receptor
Myat Lin Oo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Essential roles of sphingosine 1-phosphate/S1P(1) receptor axis in the migration of neural stem cells toward a site of spinal cord injury
Atsushi Kimura et al.
STEM CELLS (2007)
A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model
Shifeng Pan et al.
CHEMISTRY & BIOLOGY (2006)
Signaling between glia and neurons: focus on synaptic plasticity
NJ Allen et al.
CURRENT OPINION IN NEUROBIOLOGY (2005)
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients
SR Schwab et al.
SCIENCE (2005)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice
M Webb et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors
MH Graler et al.
FASEB JOURNAL (2004)
Lysophospholipid receptors: Signaling and biology
I Ishii et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Constitutive expression of the SlP(1) receptor in adult tissues
SS Chae et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2004)
Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes
NC Yu et al.
GLIA (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2
SW Paugh et al.
FEBS LETTERS (2003)
Astrocyte characterization in the multiple sclerosis glial scar
JE Holley et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment
M Fujino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes
SD Sorensen et al.
MOLECULAR PHARMACOLOGY (2003)
Microglial activation state and lysophospholipid acid receptor expression
CS Tham et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2003)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain
Y Zhu et al.
GENES & DEVELOPMENT (2001)
分享论文
